(Berlin) The European Union, which has been accused of being slow in managing the COVID-19 epidemic, will expedite the approval process for improved vaccines to respond to variants of the virus, the health commissioner announced on Sunday.
“We have explored this process with the European Pharmaceuticals Company, and we have decided that it is no longer necessary to go through all the accreditation stages to get an improved vaccine by a manufacturer to fight new variants based on the existing vaccine,” she told Germany daily. Oxburg General Released Sunday.
“So without lowering the safety criteria, the availability of appropriate vaccines will be faster,” the commissioner said.
The European Commission has been widely criticized for its slow start to vaccination campaigns against COVID-19 in EU countries, not only because of certification procedures for the first vaccines, which are considered to be too long compared to the United Kingdom or the United States, but also for vaccine orders.
Although he acknowledged that he was “not satisfied” with the current situation, the health commissioner spoke out against criticism of the EU.
“It is wrong to say that we only made mistakes,” he said, arguing that the EU was able to protect 700 million doses of vaccines by the end of the day. At the end of the third quarter of this year.
“Food trailblazer. Passionate troublemaker. Coffee fanatic. General analyst. Certified creator. Lifelong music expert. Alcohol specialist.”